| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $910.4M | +0.9% |
| Cost of Revenue | $277.1M | -6.1% |
| Gross Profit | $633.3M | +4.3% |
| R&D Expense | $133.8M | +2.4% |
| SG&A Expense | $405.9M | +3.3% |
| Operating Income | $68.2M | +18.9% |
| Interest Expense | $10.3M | +31.2% |
| Pre-tax Income | $61.3M | +11.9% |
| Income Tax | $21.6M | -44.7% |
| Net Income | $38.6M | +159.2% |
| EPS (Basic) | $0.28 | +411.1% |
| EPS (Diluted) | $0.28 | +411.1% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $241.4M | -14.4% |
| Accounts Receivable | $190.5M | +1.1% |
| Inventory | $14.2M | +12.5% |
| Current Assets | $573.2M | -7.5% |
| Total Assets | $2.23B | -3.8% |
| Current Liabilities | $418.2M | -11.2% |
| Long-term Debt | $411.0M | +0.5% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $150.6M | +7.7% |
| Capital Expenditures | $16.1M | -42.3% |
| Investing Cash Flow | -$37.4M | +33.9% |
| Financing Cash Flow | -$153.4M | +2.9% |
| Free Cash Flow | $134.5M | +20.3% |
| Total Liabilities |
| $957.4M |
| -6.1% |
| Stockholders' Equity | $830.0M | -3.0% |